Page 13 - Nasdaq Podd News Today

HMS Capital Management LLC lowered its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 11.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,383 shares of the medical instruments supplier’s stock after selling 296 shares during the […]

Research analysts at UBS Group began coverage on shares of Insulet (NASDAQ:PODD – Get Rating) in a note issued to investors on Tuesday, The Fly reports. The firm set a “neutral” rating on the medical instruments supplier’s stock. Other equities analysts also recently issued research reports about the company. Morgan Stanley increased their price target […]

Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by Raymond James from $320.00 to $334.00 in a research report released on Friday morning, The Fly reports. They currently have an outperform rating on the medical instruments supplier’s stock. A number of other research analysts have also recently issued reports on the stock. Canaccord […]

Advisor Group Holdings Inc. increased its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 15.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,484 shares of the medical instruments supplier’s stock after buying an additional 856 shares during […]

Insulet Co. (NASDAQ:PODD – Get Rating) Director Shacey Petrovic sold 15,000 shares of the business’s stock in a transaction on Friday, July 1st. The shares were sold at an average price of $222.90, for a total transaction of $3,343,500.00. Following the transaction, the director now owns 13,695 shares in the company, valued at approximately $3,052,615.50. […]

Fifth Third Bancorp increased its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,287 shares of the medical instruments supplier’s stock after buying an additional 209 shares during the quarter. Fifth […]

State of Alaska Department of Revenue lessened its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 24.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,451 shares of the medical instruments supplier’s stock after selling 4,390 shares during […]

Shares of Insulet Co. (NASDAQ:PODD – Get Rating) have received an average rating of “Buy” from the fifteen analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average […]

Brokerages predict that Insulet Co. (NASDAQ:PODD – Get Rating) will announce $289.59 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Insulet’s earnings, with the highest sales estimate coming in at $301.30 million and the lowest estimate coming in at $286.40 million. Insulet posted sales of $263.20 […]

Insulet Co. (NASDAQ:PODD – Get Rating) COO Charles Alpuche sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $215.32, for a total transaction of $1,291,920.00. Following the completion of the sale, the chief operating officer now directly owns 43,899 […]